{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:19:05Z","timestamp":1789017545544,"version":"build-2803163510"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2018,4,2]],"date-time":"2018-04-02T00:00:00Z","timestamp":1522627200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007903","name":"Bloodwise","doi-asserted-by":"publisher","award":["15037"],"award-info":[{"award-number":["15037"]}],"id":[{"id":"10.13039\/501100007903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007903","name":"Bloodwise","doi-asserted-by":"publisher","award":["REC 04\/01\/1205\/69"],"award-info":[{"award-number":["REC 04\/01\/1205\/69"]}],"id":[{"id":"10.13039\/501100007903","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Leeds West Research Ethics Committee"},{"name":"NHS"},{"name":"Health & Social Care Act","award":["PIAG 1\u201305(h)\/2007"],"award-info":[{"award-number":["PIAG 1\u201305(h)\/2007"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6,1]]},"DOI":"10.1093\/ije\/dyy044","type":"journal-article","created":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T07:44:10Z","timestamp":1520322250000},"page":"700-700g","source":"Crossref","is-referenced-by-count":51,"title":["Cohort Profile: The Haematological Malignancy Research Network (HMRN): a UK population-based patient cohort"],"prefix":"10.1093","volume":"47","author":[{"given":"Alexandra","family":"Smith","sequence":"first","affiliation":[{"name":"Department of Health Sciences, University of York, York, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Howell","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of York, York, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Crouch","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of York, York, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Painter","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of York, York, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Blase","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of York, York, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-I","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of York, York, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Hewison","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of York, York, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Bagguley","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of York, York, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Appleton","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of York, York, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Kinsey","sequence":"additional","affiliation":[{"name":"Paediatric Haematology and Oncology Unit, Leeds General Infirmary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Burton","sequence":"additional","affiliation":[{"name":"St James\u2019s Institute of Oncology, Leeds Teaching Hospitals NHS Trust, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Patmore","sequence":"additional","affiliation":[{"name":"Queens Centre for Oncology, Castle Hill Hospital, Cottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eve","family":"Roman","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of York, York, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,4,2]]},"reference":[{"key":"key\n\t\t\t\t20180618193200_dyy044-B1","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B2","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B3","volume-title":"Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","author":"Jaffe","year":"2001"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B4","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th edn","author":"Swerdlow","year":"2008"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B5","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B6","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","article-title":"The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications","volume":"117","author":"Campo","year":"2011","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B7","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012","volume":"49","author":"Ferlay","year":"2013","journal-title":"Eur J Cancer"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B8","author":"NCIN","year":"2014"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B9","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0140-6736(14)62038-9","article-title":"Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2)","volume":"385","author":"Allemani","year":"2015","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B10","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.1182\/blood-2011-02-337964","article-title":"Incidence of the myelodysplastic syndromes using a novel claims-based algorithm: high number of uncaptured cases by cancer registries","volume":"117","author":"Cogle","year":"2011","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.leukres.2014.11.025","article-title":"The use of medical claims to assess incidence, diagnostic procedures and initial treatment of myelodysplastic syndromes and chronic myelomonocytic leukemia in the Netherlands","volume":"39","author":"Dinmohamed","year":"2015","journal-title":"Leuk Res"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B12","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0140-6736(04)17670-8","article-title":"External validity of randomised controlled trials: \u2018to whom do the results of this trial apply?\u2019","volume":"365","author":"Rothwell","year":"2005","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B13","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/ije\/dyp305","article-title":"Commentary: External validity of results of randomized trials: disentangling a complex concept","volume":"39","author":"Rothwell","year":"2010","journal-title":"Int J Epidemiol"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B14","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1002\/cncr.21907","article-title":"Generalizability of cancer clinical trial results: prognostic differences between participants and nonparticipants","volume":"106","author":"Elting","year":"2006","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B15","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1007\/s00464-008-0203-7","article-title":"Analysis of patient selection and external validity in the Swedish contribution to the COLOR trial","volume":"23","author":"Janson","year":"2009","journal-title":"Surg Endosc"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B16","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/SLA.0b013e31822a7047","article-title":"Cancer trials versus the real world in the United States","volume":"254","author":"Al-Refaie","year":"2011","journal-title":"Ann Surg"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B17","doi-asserted-by":"crossref","first-page":"f6409.","DOI":"10.1136\/bmj.f6409","article-title":"Making inferences on treatment effects from real world data: propensity scores, confounding by indication, and other perils for the unwary in observational research","volume":"347","author":"Freemantle","year":"2013","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B18","doi-asserted-by":"crossref","first-page":"dju051","DOI":"10.1093\/jnci\/dju051","article-title":"External validity of a trial comprised of elderly patients with hormone receptor-positive breast cancer","volume":"106","author":"Van der Water","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B19","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1001\/jama.291.22.2720","article-title":"Participation in cancer clinical trials: race-, sex-, and age-based disparities","volume":"291","author":"Murthy","year":"2004","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B20","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1177\/1740774512458992","article-title":"Barriers to therapeutic clinical trials enrollment: differences between African-American and white cancer patients identified at the time of eligibility assessment","volume":"9","author":"Penberthy","year":"2012","journal-title":"Clinical Trials"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B21","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1002\/cncr.28168","article-title":"Inclusion of minorities and women in cancer clinical trials, a decade later: have we improved?","volume":"119","author":"Kwiatkowski","year":"2013","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B22","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1200\/JCO.2012.45.0999","article-title":"Effect of patient socioeconomic status on access to early-phase cancer trials","volume":"31","author":"Mohd Noor","year":"2013","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B23","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1200\/JCO.2012.45.4553","article-title":"Patient income level and cancer clinical trial participation","volume":"31","author":"Unger","year":"2013","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B24","doi-asserted-by":"crossref","first-page":"4208","DOI":"10.1200\/JCO.2012.42.2659","article-title":"Methods in comparative effectiveness research","volume":"30","author":"Armstrong","year":"2012","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B25","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1200\/JCO.2012.41.6701","article-title":"Comparative effectiveness research in oncology methodology: observational data","volume":"30","author":"Hershman","year":"2012","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B26","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/bjs.9166","article-title":"Population-based data from the Swedish Colon Cancer Registry","volume":"100","author":"Kodeda","year":"2013","journal-title":"Br J Surg"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B27","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1634\/theoncologist.2012-0414","article-title":"First-line treatment patterns and clinical outcomes in patients with HER2-positive and hormone receptor-positive metastatic breast cancer from registHER","volume":"18","author":"Tripathy","year":"2013","journal-title":"Oncologist"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B28","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1365-2141.2009.08010.x","article-title":"The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research","volume":"148","author":"Smith","year":"2010","journal-title":"Br J Haematol"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B29","author":"Department of Health","year":"2007"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B30","author":"Department of Health","year":"2011"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B31","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1038\/bjc.2011.450","article-title":"Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network","volume":"105","author":"Smith","year":"2011","journal-title":"Br J Cancer"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B32","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1038\/bjc.2015.94","article-title":"Lymphoma incidence, survival and prevalence 2004\u20132014: sub-type analyses from the UK\u2019s Haematological Malignancy Research Network","volume":"112","author":"Smith","year":"2015","journal-title":"Br J Cancer"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B33","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.canep.2016.03.011","article-title":"Myeloid malignancies in the real-world: Occurrence, progression and survival in the UK\u2019s population-based Haematological Malignancy Research Network 2004\u201315","volume":"42","author":"Roman","year":"2016","journal-title":"Cancer Epidemiol"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B34","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.canep.2014.02.005","article-title":"Determining disease prevalence from incidence and survival using simulation techniques","volume":"38","author":"Crouch","year":"2014","journal-title":"Cancer Epidemiol"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B35","author":"Bagguley","year":"2012"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B36","doi-asserted-by":"crossref","first-page":"e004266","DOI":"10.1136\/bmjopen-2013-004266","article-title":"Determinants of survival in patients with chronic myeloid leukaemia treated in the new era of oral therapy: findings from a UK population-based patient cohort","volume":"4","author":"Smith","year":"2014","journal-title":"BMJ Open"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B37","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.canep.2015.08.015","article-title":"Impact of age and socioeconomic status on treatment and survival from aggressive lymphoma: a UK population-based study of diffuse large B-cell lymphoma","volume":"39","author":"Smith","year":"2015","journal-title":"Cancer Epidemiol"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B38","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/bjh.14513","article-title":"Multiple myeloma: routes to diagnosis, clinical characteristics and survival \u2013 findings from a UK population-based study","volume":"177","author":"Howell","year":"2017","journal-title":"Br J Haematol"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B39","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejca.2017.03.013","article-title":"Emergency admission and survival from aggressive non-Hodgkin lymphoma: A report from the UK\u2019s population-based Haematological Malignancy Research Network","volume":"78","author":"Kane","year":"2017","journal-title":"Eur J Cancer"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B40","doi-asserted-by":"crossref","first-page":"9.","DOI":"10.1186\/2052-1839-13-9","article-title":"Time-to-diagnosis and symptoms of myeloma, lymphomas and leukaemias: a report from the Haematological Malignancy Research Network","volume":"13","author":"Howell","year":"2013","journal-title":"BMC Hematol"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B41","volume-title":"Improving Outcomes in Haematological Cancers: The Manual","author":"National Institute for Health and Care Excellence","year":"2003"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B42","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1472-684X-9-9","article-title":"Destined to die in hospital? Systematic review and meta-analysis of place of death in haematological malignancy","volume":"9","author":"Howell","year":"2010","journal-title":"BMC Palliat Care"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B43","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1136\/bmjspcare-2013-000578","article-title":"Variations in specialist palliative care referrals: findings from a population-based patient cohort of acute myeloid leukaemia, diffuse large B-cell lymphoma and myeloma","volume":"5","author":"Howell","year":"2015","journal-title":"BMJ Support Palliat Care"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B44","doi-asserted-by":"crossref","first-page":"42.","DOI":"10.1186\/1472-684X-12-42","article-title":"Place of death in haematological malignancy: variations by disease sub-type and time from diagnosis to death","volume":"12","author":"Howell","year":"2013","journal-title":"BMC Palliat Care"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B45","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/bmjspcare-2014-000793","article-title":"Preferred and actual place of death in haematological malignancy","volume":"7","author":"Howell","year":"2017","journal-title":"BMJ Support Palliat Care"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B46","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1177\/0269216313512012","article-title":"End-of-life care and achieving preferences for place of death in England: results of a population-based survey using the VOICES-SF questionnaire","volume":"28","author":"Hunt","year":"2014","journal-title":"Palliat Med"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B47","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/bmjspcare-2016-001289","article-title":"Determinants of hospital death in haematological cancers: findings from a qualitative study","volume":"8","author":"McCaughan","year":"2018","journal-title":"BMJ Support Palliat Care"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B48","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1186\/s12885-016-2835-7","article-title":"Phase-specific and lifetime costs of cancer care in Ontario, Canada","volume":"16","author":"De Oliveira","year":"2016","journal-title":"BMC Cancer"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B49","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/jnci\/djq495","article-title":"Projections of the cost of cancer care in the United States: 2010-2020","volume":"103","author":"Mariotto","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B50","author":"NHS England. Programme Budgeting","year":"2016"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B51","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jval.2013.12.007","article-title":"Long-term medical costs and life expectancy of acute myeloid leukemia: a probabilistic decision model","volume":"17","author":"Wang","year":"2014","journal-title":"Value Health"},{"key":"key\n\t\t\t\t20180618193200_dyy044-B52","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10198-016-0775-4","article-title":"Treatment cost and life expectancy of diffuse large B-cell lymphoma (DLBCL): a discrete event simulation model on a UK population-based observational cohort","volume":"18","author":"Wang","year":"2017","journal-title":"Eur J Health Econ"}],"container-title":["International Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ije\/article-pdf\/47\/3\/700\/25058934\/dyy044.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T04:30:16Z","timestamp":1570854616000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ije\/article\/47\/3\/700\/4958802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,2]]},"references-count":52,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,4,2]]},"published-print":{"date-parts":[[2018,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ije\/dyy044","relation":{},"ISSN":["0300-5771","1464-3685"],"issn-type":[{"value":"0300-5771","type":"print"},{"value":"1464-3685","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,6]]},"published":{"date-parts":[[2018,4,2]]}}}